WithdrawnNot Applicable

A Pilot Study to Explore the Role of Gut Flora in Epidermolysis Bullosa

Stopped: Company shifted focus

United States0Started 2020-03-02

Plain-language summary

This study seeks to correlate microbiome sequencing data with information provided by patients and their medical records.

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

✓. Signed informed consent, demonstrating that the patient understands the procedures required for the study and the purpose of the study i. May be signed by parent or legal guardian in the case of minor or adult unable to provide consent
✓. Male or female of all ages. (interest is given to children who present with autism or Crohn's and whose parents wish to analyze their children's gut flora. Also of interest analysis of development of the child's microbiome. In the case of autism, the younger the child, the better to correct the neurological problems if an association is found between autism and the microbiome)
✓. Diagnosis of Epidermolysis by at least one of the following i. Biopsy ii. Genetic testing

✕. Refusal to sign informed consent form
✕. History of bariatric surgery, total colectomy with ileorectal anastomosis or proctocolectomy.
✕. Postoperative stoma, ostomy, or ileoanal pouch
✕. Participation in any experimental drug protocol within the past 12 weeks
✕. Treatment with total parenteral nutrition

Correlation of Microbiome to Disease via Relative Abundance Found in Microbiome Sequencing

Timeframe: Three years

NCT IDNCT04213703

SponsorProgenaBiome

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2030-03